Surgery Partners Inc (SGRY) recent activity suggests a positive outlook with the last week’s performance of 10.22%

On Friday, Surgery Partners Inc (NASDAQ: SGRY) opened higher 4.13% from the last session, before settling in for the closing price of $30.75. Price fluctuations for SGRY have ranged from $22.05 to $39.99 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

A company in the Healthcare sector has jumped its sales by 9.35% annually for the last half of the decade. Company’s average yearly earnings per share was noted 3.77% at the time writing. With a float of $72.42 million, this company’s outstanding shares have now reached $126.59 million.

In an organization with 13500 employees, it is important to assess its efficiency.

Surgery Partners Inc (SGRY) Insider and Institutional Ownership

A key investor’s attitude towards the stock of the Medical Care Facilities industry is another important factor to consider. The insider ownership of Surgery Partners Inc is 43.02%, while institutional ownership is 66.18%. The most recent insider transaction that took place on Jun 12 ’24, was worth 158,310. In this transaction Chief Human Resources Officer of this company sold 6,000 shares at a rate of $26.39, taking the stock ownership to the 30,354 shares. Before that another transaction happened on May 31 ’24, when Company’s National Group President sold 6,000 for $27.65, making the entire transaction worth $165,900. This insider now owns 72,338 shares in total.

Surgery Partners Inc (SGRY) Latest Financial update

According to the Wall Street analysts, stocks earnings will be around 3.77% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 46.00% during the next five years compared to 54.69% growth over the previous five years of trading.

Surgery Partners Inc (NASDAQ: SGRY) Trading Performance Indicators

Check out the current performance indicators for Surgery Partners Inc (SGRY). In the past quarter, the stock posted a quick ratio of 1.56. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.46. Likewise, its price to free cash flow for the trailing twelve months is 23.32.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.00, a number that is poised to hit 0.20 in the next quarter and is forecasted to reach 1.27 in one year’s time.

Technical Analysis of Surgery Partners Inc (SGRY)

Let’s dig in a bit further. During the last 5-days, its volume was 1.42 million. That was better than the volume of 0.98 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 85.33%. Additionally, its Average True Range was 1.54.

During the past 100 days, Surgery Partners Inc’s (SGRY) raw stochastic average was set at 98.09%, which indicates a significant increase from 97.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 60.90% in the past 14 days, which was higher than the 47.46% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $25.89, while its 200-day Moving Average is $28.47. However, in the short run, Surgery Partners Inc’s stock first resistance to watch stands at $32.53. Second resistance stands at $33.03. The third major resistance level sits at $33.86. If the price goes on to break the first support level at $31.20, it is likely to go to the next support level at $30.37. The third support level lies at $29.87 if the price breaches the second support level.

Surgery Partners Inc (NASDAQ: SGRY) Key Stats

There are currently 127,094K shares outstanding in the company with a market cap of 4.07 billion. Presently, the company’s annual sales total 2,743 M according to its annual income of -11,900 K. Last quarter, the company’s sales amounted to 717,400 K and its income totaled -12,400 K.